טוען...
Cathepsin L targeting in cancer treatment
Proteolytic enzymes may serve as promising targets for novel therapeutic treatment strategies seeking to impede cancer progression and metastasis. One such enzyme is cathepsin L (CTSL), a lysosomal cysteine protease. CTSL upregulation, a common occurrence in a variety of human cancers, has been wide...
שמור ב:
| הוצא לאור ב: | Pharmacol Ther |
|---|---|
| Main Authors: | , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
2015
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4624022/ https://ncbi.nlm.nih.gov/pubmed/26299995 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.pharmthera.2015.08.007 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|